Literature DB >> 4148915

Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.

G R Breese, T D Traylor.   

Abstract

1. Brain noradrenaline, dopamine and tyrosine hydroxylase were found in rat brain a few days before birth and increased progressively until reaching adult values. The most rapid period of growth for these substances seemed to occur between 7 and 18 days.2. The intracisternal administration of 6-hydroxydopamine to rats 7 days of age reduced concentrations of noradrenaline, dopamine, and tyrosine hydroxylase by 72 hours.3. The concentrations of noradrenaline, dopamine or tyrosine hydroxylase in rats that received 6-hydroxydopamine at 7 or 14 days of age remained markedly reduced when determined at adulthood, indicating that fibres did not continue to develop after the administration of this compound. The rats treated at 7 days also showed diminished concentrations of noradrenaline in heart.4. Rats injected with 6-hydroxydopamine at 7 days had reduced body weight as well as a reduction of some organ weights. This growth deficit was not observed in animals that received this drug at 14 days of age.5. The administration of ovine growth hormone to rats that received 6-hydroxydopamine at 7 days did not reverse the growth deficiency in these animals.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4148915      PMCID: PMC1666100          DOI: 10.1111/j.1476-5381.1972.tb07257.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus.

Authors:  S P GROSSMAN
Journal:  Science       Date:  1960-07-29       Impact factor: 47.728

2.  Bioassay of hypophyseal growth hormone; the tibia test.

Authors:  F S GREENSPAN; C H LI
Journal:  Endocrinology       Date:  1949-11       Impact factor: 4.736

3.  Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine.

Authors:  L Stein; C D Wise
Journal:  Science       Date:  1971-03-12       Impact factor: 47.728

4.  Developmental changes in monoamines of mouse brain.

Authors:  H C Agrawal; S N Glisson; W A Himwich
Journal:  Int J Neuropharmacol       Date:  1968-03

5.  Regional changes in monoamines of the rat brain during postnatal development.

Authors:  L A Loizou; P Salt
Journal:  Brain Res       Date:  1970-06-15       Impact factor: 3.252

6.  Subcellular localization of tyrosine hydroxylase in beef caudate nucleus.

Authors:  P L McGeer; S P Bagchi; E G McGeer
Journal:  Life Sci       Date:  1965-10       Impact factor: 5.037

7.  Distribution of tyrosine hydroxylase activity in adult and developing brain.

Authors:  E G McGeer; S Gibson; J A Wada; P L McGeer
Journal:  Can J Biochem       Date:  1967-12

8.  Adrenergic receptor control mechanism for growth hormone secretion.

Authors:  W G Blackard; S A Heidingsfelder
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

9.  Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock.

Authors:  J M Musacchio; L Julou; S S Kety; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.

Authors:  F E Bloom; S Algeri; A Groppetti; A Revuelta; E Costa
Journal:  Science       Date:  1969-12-05       Impact factor: 47.728

View more
  27 in total

1.  BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN.

Authors:  George R Breese; Barrett R Cooper; Ronald D Smith
Journal:  Biochem Pharmacol       Date:  1974-04       Impact factor: 5.858

2.  Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist.

Authors:  H E Criswell; R A Mueller; G R Breese
Journal:  Brain Res       Date:  1990-04-02       Impact factor: 3.252

3.  Modeling of chronic selective inhibition of noradrenaline synthesis in the brain of neonatal rats.

Authors:  Y O Zubova; N S Bondarenko; A Ja Sapronova; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2015-05-05       Impact factor: 0.788

4.  The chronic inhibition of dopamine synthesis in the brain of neonatal rats as an evidence of its endocrine function in ontogeny.

Authors:  Yu O Zubova; Yu Yu Saifetyarova; A Ya Sapronova; M V Ugryumov
Journal:  Dokl Biol Sci       Date:  2014-03-22

5.  The cyclic AMP response to noradrenalin in young adult rat brain following post-natal injections of 6-hydroxydopamine.

Authors:  G C Palmer; H R Scott
Journal:  Experientia       Date:  1974-05-15

6.  Histochemical studies on the morphology of the Golgi apparatus and its relationship to catecholamine biosynthesis in the locus coeruleus of the rat.

Authors:  K Iijima; N Awazi
Journal:  Z Zellforsch Mikrosk Anat       Date:  1973

7.  Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.

Authors:  B A Shaywitz; M H Teicher; D J Cohen; G M Anderson; J G Young; P Levitt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.

Authors:  Richard M Kostrzewa; John P Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Is there a "dopaminergic glial cell"?

Authors:  E Hansson; L Rönnbäck; A Sellström
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

10.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

Authors:  G R Breese; A A Baumeister; T J McCown; S G Emerick; G D Frye; K Crotty; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.